adesso SE

XTRA:ADN1 Rapport sur les actions

Capitalisation boursière : €571.8m

adesso Résultats passés

Passé contrôle des critères 2/6

Les bénéfices de adesso ont diminué à un taux annuel moyen de -21.2%, tandis que le secteur IT a vu ses bénéfices augmenter de en à 5.9% par an. Les revenus ont augmenté de en à un taux moyen de 23% par an. Le rendement des capitaux propres de adesso est 3% et ses marges nettes sont de 0.4%.

Informations clés

-21.2%

Taux de croissance des bénéfices

-22.0%

Taux de croissance du BPA

IT Croissance de l'industrie14.0%
Taux de croissance des recettes23.0%
Rendement des fonds propres3.0%
Marge nette0.4%
Dernière mise à jour des bénéfices30 Sep 2024

Mises à jour récentes des performances passées

adesso (ETR:ADN1) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Nov 22
adesso (ETR:ADN1) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Investors Can Find Comfort In adesso's (ETR:ADN1) Earnings Quality

Apr 02
Investors Can Find Comfort In adesso's (ETR:ADN1) Earnings Quality

Recent updates

adesso (ETR:ADN1) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Nov 22
adesso (ETR:ADN1) Is Posting Promising Earnings But The Good News Doesn’t Stop There

adesso SE (ETR:ADN1) Just Reported, And Analysts Assigned A €122 Price Target

Nov 17
adesso SE (ETR:ADN1) Just Reported, And Analysts Assigned A €122 Price Target

Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?

Nov 02
Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?

It's Down 25% But adesso SE (ETR:ADN1) Could Be Riskier Than It Looks

Aug 28
It's Down 25% But adesso SE (ETR:ADN1) Could Be Riskier Than It Looks

adesso's (ETR:ADN1) Shareholders Will Receive A Bigger Dividend Than Last Year

May 21
adesso's (ETR:ADN1) Shareholders Will Receive A Bigger Dividend Than Last Year

adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.70

Apr 19
adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.70

Returns On Capital Signal Tricky Times Ahead For adesso (ETR:ADN1)

Apr 18
Returns On Capital Signal Tricky Times Ahead For adesso (ETR:ADN1)

Investors Can Find Comfort In adesso's (ETR:ADN1) Earnings Quality

Apr 02
Investors Can Find Comfort In adesso's (ETR:ADN1) Earnings Quality

Analysts Are Updating Their adesso SE (ETR:ADN1) Estimates After Its Annual Results

Mar 28
Analysts Are Updating Their adesso SE (ETR:ADN1) Estimates After Its Annual Results

Is adesso SE (ETR:ADN1) Trading At A 44% Discount?

Mar 23
Is adesso SE (ETR:ADN1) Trading At A 44% Discount?

adesso SE (ETR:ADN1) Soars 29% But It's A Story Of Risk Vs Reward

Mar 08
adesso SE (ETR:ADN1) Soars 29% But It's A Story Of Risk Vs Reward

A Look At The Intrinsic Value Of adesso SE (ETR:ADN1)

Dec 14
A Look At The Intrinsic Value Of adesso SE (ETR:ADN1)

Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?

Oct 11
Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?

At €106, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?

Jul 22
At €106, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?

Calculating The Intrinsic Value Of adesso SE (ETR:ADN1)

Jun 15
Calculating The Intrinsic Value Of adesso SE (ETR:ADN1)

adesso's (ETR:ADN1) Returns On Capital Not Reflecting Well On The Business

May 09
adesso's (ETR:ADN1) Returns On Capital Not Reflecting Well On The Business

What Does adesso SE's (ETR:ADN1) Share Price Indicate?

Apr 22
What Does adesso SE's (ETR:ADN1) Share Price Indicate?

adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet

Feb 11
adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet

Returns On Capital At adesso (ETR:ADN1) Have Stalled

Jan 26
Returns On Capital At adesso (ETR:ADN1) Have Stalled

Calculating The Fair Value Of adesso SE (ETR:ADN1)

Jan 10
Calculating The Fair Value Of adesso SE (ETR:ADN1)

At €138, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?

Dec 14
At €138, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?

We Think adesso (ETR:ADN1) Can Stay On Top Of Its Debt

Aug 22
We Think adesso (ETR:ADN1) Can Stay On Top Of Its Debt

Why adesso SE (ETR:ADN1) Could Be Worth Watching

Aug 07
Why adesso SE (ETR:ADN1) Could Be Worth Watching

adesso (ETR:ADN1) Hasn't Managed To Accelerate Its Returns

Jul 21
adesso (ETR:ADN1) Hasn't Managed To Accelerate Its Returns

Is adesso (ETR:ADN1) A Risky Investment?

May 12
Is adesso (ETR:ADN1) A Risky Investment?

Is It Too Late To Consider Buying adesso SE (ETR:ADN1)?

Apr 29
Is It Too Late To Consider Buying adesso SE (ETR:ADN1)?

adesso (ETR:ADN1) Might Be Having Difficulty Using Its Capital Effectively

Apr 12
adesso (ETR:ADN1) Might Be Having Difficulty Using Its Capital Effectively

Should You Be Adding adesso (ETR:ADN1) To Your Watchlist Today?

Mar 29
Should You Be Adding adesso (ETR:ADN1) To Your Watchlist Today?

Is There Now An Opportunity In adesso SE (ETR:ADN1)?

Jan 13
Is There Now An Opportunity In adesso SE (ETR:ADN1)?

I Ran A Stock Scan For Earnings Growth And adesso (ETR:ADN1) Passed With Ease

Dec 27
I Ran A Stock Scan For Earnings Growth And adesso (ETR:ADN1) Passed With Ease

adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet

Oct 16
adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet

Why adesso SE (ETR:ADN1) Could Be Worth Watching

Sep 28
Why adesso SE (ETR:ADN1) Could Be Worth Watching

Do adesso's (ETR:ADN1) Earnings Warrant Your Attention?

Aug 23
Do adesso's (ETR:ADN1) Earnings Warrant Your Attention?

Ventilation des recettes et des dépenses

Comment adesso gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

XTRA:ADN1 Recettes, dépenses et bénéfices (EUR Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Sep 241,2695200
30 Jun 241,225-1200
31 Mar 241,182-2200
31 Dec 231,1403200
30 Sep 231,0845160
30 Jun 231,03712160
31 Mar 2396918160
31 Dec 2290129160
30 Sep 2283629110
30 Jun 2276928110
31 Mar 2272537110
31 Dec 2167848110
30 Sep 216364590
30 Jun 216004690
31 Mar 215644290
31 Dec 205242190
30 Sep 205032440
30 Jun 204841990
31 Mar 204671890
31 Dec 194511790
30 Sep 1943215110
30 Jun 1941213140
31 Mar 1939513140
31 Dec 1837814140
30 Sep 1836414140
30 Jun 1835114140
31 Mar 1833613140
31 Dec 1732211140
30 Sep 1730711130
30 Jun 1729211120
31 Mar 1727612120
31 Dec 1626112120
30 Sep 1624510100
30 Jun 16229790
31 Mar 16213690
31 Dec 15197590
30 Sep 15183470
30 Jun 15169440
31 Mar 15163440
31 Dec 14157340
30 Sep 14151340
30 Jun 14145240
31 Mar 14140340
31 Dec 13135340

Des revenus de qualité: ADN1 a des bénéfices de haute qualité.

Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de ADN1 sont inférieures à celles de l'année dernière ADN1. (0.4%) sont inférieures à celles de l'année dernière (0.4%).


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: Les bénéfices de ADN1 ont diminué de 21.2% par an au cours des 5 dernières années.

Accélération de la croissance: La croissance des bénéfices de ADN1 au cours de l'année écoulée ( 0.09% ) dépasse sa moyenne sur 5 ans ( -21.2% par an).

Bénéfices par rapport au secteur d'activité: La croissance des bénéfices ADN1 au cours de l'année écoulée ( 0.09% ) n'a pas surpassé celle du secteur IT 8.5%.


Rendement des fonds propres

ROE élevé: Le retour sur capitaux propres de ADN1 ( 3% ) est considéré comme faible.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé